BioSpace News Archive

Karolinska Development’s portfolio company Dilafor secures financing for continued development of tafoxiparin

Karolinska Development AB announces that its portfolio company Dilafor AB has completed a capital raising and is planning to start a new Phase 2b study of tafoxiparin to soften the cervix prior to labor induction.

April 24, 2019
·
4 min read
Drug Development

Galapagos and MorphoSys announce initiation of GECKO Phase 2 study with MOR106 in atopic dermatitis patients

Galapagos NV, MorphoSys AG and Novartis Pharma AG announced the initiation of GECKO, a Phase 2 study testing a subcutaneous formulation of MOR106 in combination with topical corticosteroids in patients with moderate to severe atopic dermatitis.

April 24, 2019
·
6 min read
Pharm Country

Despite a Q1 Drop in Sales, J&J Anticipates New Indications Will Increase Xarelto Revenue Growth

Life sciences giant blamed the Medicare “doughnut hole” and increased competition for the blood thinner’s declining sales.

April 24, 2019
·
2 min read
·
Alex Keown
Drug Development

Soligenix - Advancing to Important Inflection Points With Two Pivotal Phase 3 Clinical Trials - April 23, 2019

Soligenix, Inc. issued an update letter from its President and Chief Executive Officer, Dr. Christopher J. Schaber.

April 24, 2019
·
14 min read
BioCapital

Pharma Regulatory and Pricing Updates; Sign Up for a Complimentary Inside Health Policy Trial

Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.

April 24, 2019
·
4 min read
Biotech Beach

Arcutis, Inc. Founded to Address Gap in Immuno-Dermatology Drug Development

Arcutis, Inc., a privately held immuno-dermatology drug development company, was formed in 2016 to address significant unmet needs in dermatology.

April 24, 2019
·
4 min read
Genetown

Fulcrum Therapeutics Licenses Failed GSK Drug for Possible Muscular Dystrophy Indication

Cambridge, Mass.-based Fulcrum Therapeutics just acquired a worldwide license with GlaxoSmithKline (GSK) to develop and commercialize losmapimod.

April 24, 2019
·
2 min read
·
Mark Terry
Business

Accenture’s New Science Report: An Interview With Stuart Henderson

Accenture recently published a new report, “New Science: Biopharma’s New Growth Machine.” In it, the report attempts to evaluate the last 20 years of trends in biopharma and use that data to develop projections for the future of the industry.

April 24, 2019
·
6 min read
·
Mark Terry
Business

Academic entrepreneur Brian Bellhouse celebrated with naming of new building

Turf cutting for the Bellhouse Building to be performed by Lord & Lady Drayson

April 24, 2019
·
3 min read
Policy

A Faster And More Accurate Diagnostic Test For Mosquito-borne Diseases In The Works

Singapore scientists are developing a single test that can detect and differentiate multiple mosquito-borne viruses and their types

April 24, 2019
·
4 min read